| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,898 |
9,878 |
$1.31M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,588 |
3,499 |
$416K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,282 |
2,988 |
$383K |
| S9083 |
Global fee urgent care centers |
1,919 |
1,729 |
$154K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
947 |
896 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,347 |
1,204 |
$804.14 |
| 81003 |
|
390 |
372 |
$466.59 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
746 |
733 |
$311.40 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
397 |
387 |
$232.46 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
40 |
38 |
$135.69 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
459 |
443 |
$5.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
27 |
$2.09 |